Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Neurodegenerative Diseases Progression Markers (MARKERS-NDD): a Real-world Data Longitudinal Prospective Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06596746
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:26:12.225368+00:00
Published At
2024-09-19T00:00:00+00:00
Record Updated At
2024-09-19
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Neurodegenerative Diseases", "Parkinson Disease", "Synucleinopathies", "Lewy Body Disease", "Multiple System Atrophy", "Tauopathies", "Alzheimer Disease", "Corticobasal Degeneration", "Supranuclear Palsy, Progressive", "Atypical Parkinsonism", "TDP-43 Proteinopathies", "Amyotrophic Lateral Sclerosis", "Frontotemporal Lobar Degeneration", "Movement Disorders", "Cognitive Impairment", "Dementia", "Iron Overload", "Neurodegeneration With Brain Iron Accumulation (NBIA)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-09-19"
protocolSection.identificationModule.nctId
"NCT06596746"
protocolSection.identificationModule.officialTitle
"Neurodegenerative Diseases Progression Markers (MARKERS-NDD): a Real-world Data Longitudinal Prospective Study"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Neurodegenerative Diseases (protocolSection.conditionsModule.conditions)
  • Parkinson Disease (protocolSection.conditionsModule.conditions)
  • Synucleinopathies (protocolSection.conditionsModule.conditions)
  • Lewy Body Disease (protocolSection.conditionsModule.conditions)
  • Multiple System Atrophy (protocolSection.conditionsModule.conditions)
  • Tauopathies (protocolSection.conditionsModule.conditions)
  • Alzheimer Disease (protocolSection.conditionsModule.conditions)
  • Corticobasal Degeneration (protocolSection.conditionsModule.conditions)
  • Supranuclear Palsy, Progressive (protocolSection.conditionsModule.conditions)
  • Atypical Parkinsonism (protocolSection.conditionsModule.conditions)
  • TDP-43 Proteinopathies (protocolSection.conditionsModule.conditions)
  • Amyotrophic Lateral Sclerosis (protocolSection.conditionsModule.conditions)
  • Frontotemporal Lobar Degeneration (protocolSection.conditionsModule.conditions)
  • Movement Disorders (protocolSection.conditionsModule.conditions)
  • Cognitive Impairment (protocolSection.conditionsModule.conditions)
  • Dementia (protocolSection.conditionsModule.conditions)
  • Iron Overload (protocolSection.conditionsModule.conditions)
  • Neurodegeneration With Brain Iron Accumulation (NBIA) (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.